Jersey City, New Jersey, April 06, 2021 (GLOBE NEWSWIRE) -- Verified Market Research recently published a report, “Anticoagulant Reversal Drugs Market” by Product Type (Prothrombin Complex Concentrates, Phytonadione, Andexanet Alfa, Idarucizumab, Protamine, and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by Geography. According to Verified Market Research, the Global Anticoagulant Reversal Drugs Market was valued at USD 985.34 Million in 2020 and is projected to reach USD 2,518.06 Million by 2028, growing at a CAGR of 12.65% from 2021 to 2028.
Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample/?rid=129031
Browse in-depth TOC on “Anticoagulant Reversal Drugs Market”
202 - Pages
126 – Tables
37 – Figures
Global Anticoagulant Reversal Drugs Market Overview
Approval and launch of new therapies, increasing prevalence of bleeding disorders, and rise in the incidence of indications for anticoagulant therapy are some of the major factors driving the market. Approval and launch of new reversal agents for anticoagulants are significantly driving the market. For instance, in May 2018, the U.S. FDA approved Andexxa by Portola Pharmaceuticals as the first factor Xa inhibitor antidote. When an anticoagulation reversal drug is required due to uncontrolled or life-threatening bleeding, this reversal agent is indicated for patients treated with apixaban (Eliquis) and rivaroxaban (Xarelto).
The expected launch of Andexxa under an Early Supply Program with Generation 1 product was in early June. However, the company announced the first sale of Ondexxya in Europe in August 2019 due to a larger number of patients taking Factor Xa inhibitor in the region as compared to the U.S. Andexxa received both FDA breakthrough therapy and U.S. orphan drug designations. In addition, the growing burden of cardiovascular diseases globally is expected to be a major factor for the increasing demand of anticoagilant reversal drugs, which in turn surges the market growth in the coming years.
The major players in the market are Portola Pharmaceuticals; Boehringer Ingelheim; CSL Behring; Bausch Health Companies Inc.; Octapharma AG; Dr. Reddy's Laboratories; AMAG Pharmaceuticals, Inc.; Pfizer, Inc.; SGPharma Pvt. Ltd.; and Alps Pharmaceutical Ind. Co., Ltd.
Verified Market Research has segmented the Global Anticoagulant Reversal Drugs Market On the basis of Product Type, Distribution Channel, and Geography.
- Anticoagulant Reversal Drugs Market by Product Type
- Prothrombin Complex Concentrates
- Phytonadione
- Andexanet Alfa
- Idarucizumab
- Protamine
- Others
- Anticoagulant Reversal Drugs Market by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Anticoagulant Reversal Drugs Market by Geography
- North America
- U.S
- Canada
- Mexico
- Europe
- Germany
- France
- U.K
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
- ROW
- Middle East & Africa
- Latin America
- North America
Browse Related Reports:
Acute Bacterial Skin And Skin Structure Infection (ABSSSI) Market by Active Ingredient (Delafloxacin, Vancomycin, Oritavancin, Daptomycin, Others), by Route of Administration (Oral, Parenteral, Topical), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Geography, Forecast, 2020-2027
Optical Lens Edger Market by Product (Manual Optical Lens Edger, Semi-automatic Optical Lens Edger, Automatic Optical Lens Edger), by Application (Eyeglass Lens, Camera Lens, Microscope Lens, Others), by Geography, Forecast, 2020-2027
Allergic Rhinitis Market by Type (Seasonal, Perennial, Occupational Rhinitis), by Treatment (Immunotherapy, Antihistamines, Decongestants, Corticosteroids, Others), by Test (Skin Test, IgE Radioallergosorbent (RAST) Test, Complete Blood Count), by Geography, Forecast, 2020-2027
Orthopedic Implants Market by Application (Spinal Fusion, Joint Replacement, Long Bones, Craniomaxillofacial, Foot & Ankle, and Dental), by Geography, Forecast, 2020-2027
10 leading vaccine manufacturers offering immunity against the deadly viruses
Visualize Anticoagulant Reversal Drugs Market using Verified Market Intelligence:-:
Verified Market Intelligence is our BI Enabled Platform for narrative storytelling of this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue-impacting decisions for a brilliant future.
VMI provides a holistic overview and global competitive landscape with respect to Region, Country, and Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.
About Us
Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information-enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals, and critical revenue decisions.
Our 250 Analysts and SME’s offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
We study 14+ categories from Semiconductor & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & Construction, Agriculture industry and Medical Devices from over 100 countries.